✦ LIBER ✦

Sustained-release fampridine in Multiple Sclerosis

✍ Scribed by Hadavi, S.; Baker, M.D.; Dobson, R.

Book ID: 121697984
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 428 KB
Volume: 3
Category: Article
ISSN: 2211-0348
DOI: 10.1016/j.msard.2013.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose comparison trial of sustained-relea

Dose comparison trial of sustained-release fampridine in multiple sclerosis

✍ Goodman, A. D.; Brown, T. R.; Cohen, J. A.; Krupp, L. B.; Schapiro, R.; Schwid, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 626 KB

Dose comparison trial of sustained-relea

Dose comparison trial of sustained-release fampridine in multiple sclerosis

✍ Goodman, A. D.; Brown, T. R.; Cohen, J. A.; Krupp, L. B.; Schapiro, R.; Schwid, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 626 KB

Sustained-release oral fampridine in mul

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

✍ Andrew D Goodman; Theodore R Brown; Lauren B Krupp; Randall T Schapiro; Steven R 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 166 KB

Sustained-release fampridine and the rol

Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis

✍ Krishnan, A. V.; Kiernan, M. C. 📂 Article 📅 2012 🏛 SAGE Publications 🌐 English ⚖ 587 KB

Sustained-Release Fampridine (4-Aminopyr

Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function

✍ Meheroz H. Rabadi, Kimberly Kreymborg, Andrea S. Vincent 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 286 KB

Pharmacokinetics and tolerability of sin

Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial

✍ Timothy Vollmer; Herbert R. Henney III 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 224 KB